BioIntelliSense, a leader in continuous health monitoring, and Hicuity Health, a top provider of virtual care services, have announced a strategic partnership to deliver fully managed, end-to-end continuous patient monitoring for hospitals and health systems. This collaboration addresses staffing and infrastructure challenges, enabling scalable monitoring solutions for in-hospital care, hospital-at-home programs, post-discharge, and chronic remote care management.
The FDA-cleared BioButton® wearable and BioDashboard™ clinical intelligence system will integrate with Hicuity Health’s 24/7 virtual monitoring services, providing actionable insights and workflow efficiencies. Hicuity Health's extensive experience in high-acuity patient monitoring—delivering over 11 million hours annually—helps reduce the burden on on-site clinical teams.
“This partnership allows health systems of all sizes to scale continuous care programs efficiently,” said Dr. James Mault, CEO of BioIntelliSense. “By combining our award-winning technology with Hicuity Health’s expertise, we’re addressing workforce shortages while improving patient outcomes and resource efficiency.”
The rechargeable, wireless BioButton® continuously tracks vital signs, automating 1,440 daily measurements per patient. Data is analyzed by the BioDashboard and securely monitored by Hicuity Health’s clinical teams, who follow predefined protocols to support timely interventions.
“At Hicuity Health, we’re committed to advancing virtual care solutions that scale to hospital needs nationwide,” said Lou Silverman, CEO of Hicuity Health. “Partnering with BioIntelliSense enhances our ability to deliver high-quality care in both hospital and home settings.”
This collaboration provides hospitals and health systems with a seamless, scalable solution to enhance patient monitoring and optimize clinical resources.
Click here to read the original news story.